How Novartis’s CEO Learned From Mistakes and Got Help From an Unlikely Quarter
Wall Street Journal
After some deals and drug launches disappointed, Vas Narasimhan heard from investors—and hired an outspoken Wall Street analyst to manage strategy.
Wall Street Journal
After some deals and drug launches disappointed, Vas Narasimhan heard from investors—and hired an outspoken Wall Street analyst to manage strategy.